PRI:NYSEPrimerica, Inc. Analysis
Data as of 2026-05-22 - not real-time
$281.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Primerica (PRI) trades at $281, well below its DCF-derived fair value of roughly $593 and under the industry average P/E of 16.7, indicating a substantial valuation gap. The company delivered an 8.6% YoY revenue increase to $872.7 M in Q1 2026 and posted non‑GAAP EPS of $5.96, beating consensus by 8.7%, underscoring robust top‑line momentum and earnings resilience. With a trailing P/E of 11.8, a forward P/E of 10.6, a dividend yield of 1.59% and a modest payout ratio of 18%, the dividend appears sustainable given strong free cash flow of $1.07 B and a debt‑to‑equity of 73.8% that remains manageable.
Technically, the stock sits above its 20‑day SMA ($276.4) and 50‑day SMA ($266.0), the MACD line is bullish over its signal, and the RSI at 59 signals room for upside without overbought pressure. Support near $265.8 holds firm, while resistance at $286.7 aligns with recent highs, suggesting a near‑term upside target. Combined with a low beta (~0.58) and moderate 30‑day volatility (20.5%), the risk‑adjusted profile is attractive, supporting a short‑ to medium‑term buying bias.
Technically, the stock sits above its 20‑day SMA ($276.4) and 50‑day SMA ($266.0), the MACD line is bullish over its signal, and the RSI at 59 signals room for upside without overbought pressure. Support near $265.8 holds firm, while resistance at $286.7 aligns with recent highs, suggesting a near‑term upside target. Combined with a low beta (~0.58) and moderate 30‑day volatility (20.5%), the risk‑adjusted profile is attractive, supporting a short‑ to medium‑term buying bias.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover and price above 20‑day SMA
- Support holding at $265.8 with upside to $286.7
- Recent earnings beat reinforcing momentum
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation upside vs DCF fair value
- Consistent revenue growth and strong cash generation
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable business model serving middle‑income households
- Low beta and modest volatility offering defensive qualities
- Regulatory and insurance‑sector headwinds that may temper price appreciation
Key Metrics & Analysis
Financial Health
Revenue Growth8.10%
Profit Margin22.61%
P/E Ratio11.8
ROE32.34%
ROA4.63%
Debt/Equity73.79
P/B Ratio3.5
Op. Cash Flow$860.5M
Free Cash Flow$1.1B
Industry P/E16.7
Technical Analysis
TrendBullish
RSI59.5
Support$265.79
Resistance$286.74
MA 20$276.41
MA 50$265.98
MA 200$263.71
MACDBullish
VolumeDecreasing
Fear & Greed Index91.5
Valuation
Fair Value$592.96
Target Price$298.50
Upside/Downside6.23%
GradeUndervalued
TypeBlend
Dividend Yield1.59%
Risk Assessment
Beta0.58
Volatility20.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.